Patients with rheumatoid arthritis who switched biologics incurred higher costs than patients who persisted on biologics. Etanercept appeared to be associated with the lowest costs.
Hiangkiat Tan, MS, BSPharm
Advertisement
Articles by Hiangkiat Tan, MS, BSPharm
Advertisement
Latest Updated Articles
- Cost of Biologic Treatment Persistence or Switching in Rheumatoid Arthritis
Published: July 12th 2018 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
Guidelines for Bronchiectasis Highlight Multiple Treatment Methods
2
Many US Health Care Workers Face Poverty, Food Insecurity, and Housing Instability
3
Combination Therapy Proves More Effective in NSCLC Compared With Chemotherapy
4
Ongoing COVID-19 Circulation Linked to Increases in Health-Related Work Absences, Workforce Exits
5
